Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 12.3 USD 0.41% Market Closed
Market Cap: 786.7m USD
Have any thoughts about
Avid Bioservices Inc?
Write Note

Intrinsic Value

CDMO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CDMO stock under the Base Case scenario is 18.42 USD. Compared to the current market price of 12.3 USD, Avid Bioservices Inc is Undervalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CDMO Intrinsic Value
18.42 USD
Undervaluation 33%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Avid Bioservices Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CDMO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CDMO?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Avid Bioservices Inc

Provide an overview of the primary business activities
of Avid Bioservices Inc.

What unique competitive advantages
does Avid Bioservices Inc hold over its rivals?

What risks and challenges
does Avid Bioservices Inc face in the near future?

Has there been any significant insider trading activity
in Avid Bioservices Inc recently?

Summarize the latest earnings call
of Avid Bioservices Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Avid Bioservices Inc.

Provide P/S
for Avid Bioservices Inc.

Provide P/E
for Avid Bioservices Inc.

Provide P/OCF
for Avid Bioservices Inc.

Provide P/FCFE
for Avid Bioservices Inc.

Provide P/B
for Avid Bioservices Inc.

Provide EV/S
for Avid Bioservices Inc.

Provide EV/GP
for Avid Bioservices Inc.

Provide EV/EBITDA
for Avid Bioservices Inc.

Provide EV/EBIT
for Avid Bioservices Inc.

Provide EV/OCF
for Avid Bioservices Inc.

Provide EV/FCFF
for Avid Bioservices Inc.

Provide EV/IC
for Avid Bioservices Inc.

Show me price targets
for Avid Bioservices Inc made by professional analysts.

What are the Revenue projections
for Avid Bioservices Inc?

How accurate were the past Revenue estimates
for Avid Bioservices Inc?

What are the Net Income projections
for Avid Bioservices Inc?

How accurate were the past Net Income estimates
for Avid Bioservices Inc?

What are the EPS projections
for Avid Bioservices Inc?

How accurate were the past EPS estimates
for Avid Bioservices Inc?

What are the EBIT projections
for Avid Bioservices Inc?

How accurate were the past EBIT estimates
for Avid Bioservices Inc?

Compare the revenue forecasts
for Avid Bioservices Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Avid Bioservices Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Avid Bioservices Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Avid Bioservices Inc compared to its peers.

Compare the P/E ratios
of Avid Bioservices Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Avid Bioservices Inc with its peers.

Analyze the financial leverage
of Avid Bioservices Inc compared to its main competitors.

Show all profitability ratios
for Avid Bioservices Inc.

Provide ROE
for Avid Bioservices Inc.

Provide ROA
for Avid Bioservices Inc.

Provide ROIC
for Avid Bioservices Inc.

Provide ROCE
for Avid Bioservices Inc.

Provide Gross Margin
for Avid Bioservices Inc.

Provide Operating Margin
for Avid Bioservices Inc.

Provide Net Margin
for Avid Bioservices Inc.

Provide FCF Margin
for Avid Bioservices Inc.

Show all solvency ratios
for Avid Bioservices Inc.

Provide D/E Ratio
for Avid Bioservices Inc.

Provide D/A Ratio
for Avid Bioservices Inc.

Provide Interest Coverage Ratio
for Avid Bioservices Inc.

Provide Altman Z-Score Ratio
for Avid Bioservices Inc.

Provide Quick Ratio
for Avid Bioservices Inc.

Provide Current Ratio
for Avid Bioservices Inc.

Provide Cash Ratio
for Avid Bioservices Inc.

What is the historical Revenue growth
over the last 5 years for Avid Bioservices Inc?

What is the historical Net Income growth
over the last 5 years for Avid Bioservices Inc?

What is the current Free Cash Flow
of Avid Bioservices Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Avid Bioservices Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Avid Bioservices Inc

Current Assets 103.6m
Cash & Short-Term Investments 33.4m
Receivables 35.2m
Other Current Assets 35.1m
Non-Current Assets 231m
PP&E 226.4m
Other Non-Current Assets 4.7m
Current Liabilities 71.1m
Accounts Payable 20m
Accrued Liabilities 7m
Other Current Liabilities 44.1m
Non-Current Liabilities 204.9m
Long-Term Debt 160.6m
Other Non-Current Liabilities 44.3m
Efficiency

Earnings Waterfall
Avid Bioservices Inc

Revenue
180.1m USD
Cost of Revenue
-167.1m USD
Gross Profit
13m USD
Operating Expenses
-36.1m USD
Operating Income
-23m USD
Other Expenses
-123.3m USD
Net Income
-146.3m USD

Free Cash Flow Analysis
Avid Bioservices Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Avid Bioservices started fiscal 2025 robustly, reporting a 6% increase in revenues year-over-year to $40.2 million, driven primarily by higher process development revenues. Gross profit also rose to $5.7 million, representing a 14% gross margin, up from 11% the previous year. Though facing a net loss of $5.5 million, the company signed $66 million in new project agreements, achieving a record backlog of $219 million. This includes significant contributions from new customers, particularly in late-stage programs, projecting long-term revenue growth and improved margins. The team remains optimistic about continuing growth and operational improvements through the rest of the year.

What is Earnings Call?
Fundamental Scores

CDMO Profitability Score
Profitability Due Diligence

Avid Bioservices Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 3-Year Average ROE
43/100
Profitability
Score

Avid Bioservices Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

CDMO Solvency Score
Solvency Due Diligence

Avid Bioservices Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
High D/E
Positive Net Debt
22/100
Solvency
Score

Avid Bioservices Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CDMO Price Targets Summary
Avid Bioservices Inc

Wall Street analysts forecast CDMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDMO is 13.01 USD with a low forecast of 12.12 USD and a high forecast of 14.7 USD.

Lowest
Price Target
12.12 USD
1% Downside
Average
Price Target
13.01 USD
6% Upside
Highest
Price Target
14.7 USD
20% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CDMO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CDMO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CDMO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Avid Bioservices Inc Logo
Avid Bioservices Inc

Country

United States of America

Industry

Biotechnology

Market Cap

782.4m USD

Dividend Yield

0%

Description

Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

Contact

CALIFORNIA
Tustin
2642 Michelle Dr Ste 200
+17145086100.0
avidbio.com

IPO

1993-10-27

Employees

252

Officers

President, CEO & Director
Mr. Nicholas Stewart Green B.Sc., MBA
Chief Financial Officer
Mr. Daniel R. Hart
Chief Operations Officer
Mr. Richard A. Richieri
VP, General Counsel & Corporate Secretary
Mr. Mark R. Ziebell J.D.
Chief Commercial Officer
Mr. Matthew R. Kwietniak

See Also

Discover More
What is the Intrinsic Value of one CDMO stock?

The intrinsic value of one CDMO stock under the Base Case scenario is 18.42 USD.

Is CDMO stock undervalued or overvalued?

Compared to the current market price of 12.3 USD, Avid Bioservices Inc is Undervalued by 33%.

Back to Top